13F HOLDINGS REPORT
Ikarian Capital, LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001420506-23-002207
Total Value
$831.4M
Positions
140
Other Managers
0
Confidential Omitted
No
Holdings (140)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | SPY | 1,500 | $64.1M | 7.71% |
| 2 | SAREPTA THERAPEUTICS INC | SRPT | 3,673 | $44.5M | 5.36% |
| 3 | INVESCO QQQ TR | IVZ | 1,200 | $43.0M | 5.17% |
| 4 | SPDR SER TR | 78464A870 | 5,000 | $36.5M | 4.39% |
| 5 | ACELYRIN INC | 00445A100 | 2,918,426 | $29.7M | 3.57% |
| 6 | IMMUNOVANT INC | IMVT | 7,230 | $27.8M | 3.34% |
| 7 | SAREPTA THERAPEUTICS INC | SRPT | 2,123 | $25.7M | 3.10% |
| 8 | MODERNA INC | MRNA | 2,443 | $25.2M | 3.04% |
| 9 | CRINETICS PHARMACEUTICALS IN | CRNX | 792,920 | $23.6M | 2.84% |
| 10 | IMMUNOVANT INC | IMVT | 5,534 | $21.2M | 2.56% |
| 11 | ABBVIE INC | ABBV | 1,325 | $19.8M | 2.38% |
| 12 | SOLENO THERAPEUTICS INC | SLNO | 536,720 | $15.8M | 1.91% |
| 13 | AKERO THERAPEUTICS INC | 00973Y108 | 3,049 | $15.4M | 1.86% |
| 14 | CRINETICS PHARMACEUTICALS IN | CRNX | 4,543 | $13.5M | 1.63% |
| 15 | ROCKET PHARMACEUTICALS INC | RCKTW | 654,726 | $13.4M | 1.61% |
| 16 | NUVALENT INC | NUVL | 278,034 | $12.8M | 1.54% |
| 17 | BRIDGEBIO PHARMA INC | BBIO | 473,126 | $12.5M | 1.50% |
| 18 | CRINETICS PHARMACEUTICALS IN | CRNX | 4,054 | $12.1M | 1.45% |
| 19 | IMMUNOVANT INC | IMVT | 297,794 | $11.4M | 1.38% |
| 20 | NUVALENT INC | NUVL | 2,395 | $11.0M | 1.32% |
| 21 | SYNDAX PHARMACEUTICALS INC | SNDX | 7,500 | $10.9M | 1.31% |
| 22 | AKERO THERAPEUTICS INC | 00973Y108 | 200,000 | $10.1M | 1.22% |
| 23 | AKERO THERAPEUTICS INC | 00973Y108 | 1,989 | $10.1M | 1.21% |
| 24 | KRYSTAL BIOTECH INC | KRYS | 845 | $9.8M | 1.18% |
| 25 | REPLIMUNE GROUP INC | REPL | 5,438 | $9.3M | 1.12% |
| 26 | CRISPR THERAPEUTICS AG | CRSP | 2,039 | $9.3M | 1.11% |
| 27 | TARSUS PHARMACEUTICALS INC | TARS | 518,519 | $9.2M | 1.11% |
| 28 | BIOMARIN PHARMACEUTICAL INC | BMRN | 1,018 | $9.0M | 1.08% |
| 29 | APELLIS PHARMACEUTICALS INC | APLS | 2,365 | $9.0M | 1.08% |
| 30 | NOVAVAX INC | NVAX | 12,132 | $8.8M | 1.06% |
| 31 | BRIDGEBIO PHARMA INC | BBIO | 3,054 | $8.1M | 0.97% |
| 32 | VAXCYTE INC | PCVX | 142,417 | $7.3M | 0.87% |
| 33 | ARCUS BIOSCIENCES INC | RCUS | 4,000 | $7.2M | 0.86% |
| 34 | DISC MEDICINE INC | IRON | 1,526 | $7.2M | 0.86% |
| 35 | STRUCTURE THERAPEUTICS INC | GPCR | 137,824 | $6.9M | 0.84% |
| 36 | DISC MEDICINE INC | IRON | 142,766 | $6.7M | 0.81% |
| 37 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 174,945 | $6.2M | 0.75% |
| 38 | IMMUNOGEN INC | 45253H101 | 390,162 | $6.2M | 0.74% |
| 39 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 746,069 | $6.0M | 0.72% |
| 40 | CYTOKINETICS INC | CYTK | 2,035 | $6.0M | 0.72% |
| 41 | CYTOKINETICS INC | CYTK | 2,035 | $6.0M | 0.72% |
| 42 | CATALYST PHARMACEUTICALS INC | CPRX | 505,862 | $5.9M | 0.71% |
| 43 | IDEAYA BIOSCIENCES INC | IDYA | 216,949 | $5.9M | 0.70% |
| 44 | AMBRX BIOPHARMA INC | 02290A102 | 4,932 | $5.7M | 0.68% |
| 45 | IMMUNOGEN INC | 45253H101 | 3,568 | $5.7M | 0.68% |
| 46 | REVOLUTION MEDICINES INC | RVMDW | 2,035 | $5.6M | 0.68% |
| 47 | JAZZ PHARMACEUTICALS PLC | JAZZ | 418 | $5.4M | 0.65% |
| 48 | 89BIO INC | 282559103 | 3,504 | $5.4M | 0.65% |
| 49 | NOVAVAX INC | NVAX | 7,132 | $5.2M | 0.62% |
| 50 | LYRA THERAPEUTICS INC | LYRA | 1,254,384 | $4.9M | 0.59% |
| 51 | ARCUS BIOSCIENCES INC | RCUS | 254,876 | $4.6M | 0.55% |
| 52 | VENTYX BIOSCIENCES INC | 92332V107 | 1,233 | $4.3M | 0.52% |
| 53 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 178,360 | $4.1M | 0.50% |
| 54 | ACLARIS THERAPEUTICS INC | ACRS | 5,955 | $4.1M | 0.49% |
| 55 | REPLIMUNE GROUP INC | REPL | 2,325 | $4.0M | 0.48% |
| 56 | INSMED INC | INSM | 154,900 | $3.9M | 0.47% |
| 57 | PRAXIS PRECISION MEDICINES I | PRAX | 2,250,000 | $3.8M | 0.46% |
| 58 | ITEOS THERAPEUTICS INC | 46565G104 | 346,471 | $3.8M | 0.46% |
| 59 | AMYLYX PHARMACEUTICALS INC | AMLX | 2,065 | $3.8M | 0.45% |
| 60 | SYNDAX PHARMACEUTICALS INC | SNDX | 2,500 | $3.6M | 0.44% |
| 61 | EYEPOINT PHARMACEUTICALS INC | EYPT | 4,487 | $3.6M | 0.43% |
| 62 | ITEOS THERAPEUTICS INC | 46565G104 | 3,056 | $3.3M | 0.40% |
| 63 | CYMABAY THERAPEUTICS INC | 23257D103 | 2,230 | $3.3M | 0.40% |
| 64 | COHERUS BIOSCIENCES INC | CHRS | 865,787 | $3.2M | 0.39% |
| 65 | VERVE THERAPEUTICS INC | 92539P101 | 2,413 | $3.2M | 0.38% |
| 66 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,500 | $3.1M | 0.37% |
| 67 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 514,101 | $2.9M | 0.34% |
| 68 | ASTRIA THERAPEUTICS INC | 04635X102 | 374,807 | $2.8M | 0.34% |
| 69 | BIOHAVEN LTD | BHVN | 106,138 | $2.8M | 0.33% |
| 70 | LARIMAR THERAPEUTICS INC | LRMR | 682,868 | $2.7M | 0.32% |
| 71 | CELLDEX THERAPEUTICS INC NEW | CLDX | 971 | $2.7M | 0.32% |
| 72 | VERVE THERAPEUTICS INC | 92539P101 | 2,000 | $2.7M | 0.32% |
| 73 | ACLARIS THERAPEUTICS INC | ACRS | 3,637 | $2.5M | 0.30% |
| 74 | REVIVA PHARMACEUTCLS HLDGS I | 76152G100 | 5,095 | $2.5M | 0.30% |
| 75 | DYNE THERAPEUTICS INC | DYN | 2,726 | $2.4M | 0.29% |
| 76 | NUVALENT INC | NUVL | 523 | $2.4M | 0.29% |
| 77 | VOYAGER THERAPEUTICS INC | VYGR | 305,857 | $2.4M | 0.29% |
| 78 | INFLARX NV | IFRX | 688,604 | $2.1M | 0.25% |
| 79 | MERSANA THERAPEUTICS INC | 59045L106 | 1,579,770 | $2.0M | 0.24% |
| 80 | ALLAKOS INC | 01671P100 | 787,056 | $1.8M | 0.21% |
| 81 | ESPERION THERAPEUTICS INC NE | ESPR | 1,737,636 | $1.7M | 0.20% |
| 82 | NUVATION BIO INC | NUVB | 1,222,852 | $1.6M | 0.20% |
| 83 | BLACK DIAMOND THERAPEUTICS I | BDTX | 555,572 | $1.6M | 0.19% |
| 84 | APELLIS PHARMACEUTICALS INC | APLS | 412 | $1.6M | 0.19% |
| 85 | BIOVIE INC | BIVIW | 457,345 | $1.6M | 0.19% |
| 86 | CYMABAY THERAPEUTICS INC | 23257D103 | 104,300 | $1.6M | 0.19% |
| 87 | AEON BIOPHARMA INC | AEON | 257,977 | $1.4M | 0.17% |
| 88 | MILESTONE PHARMACEUTICALS IN | MIST | 462,828 | $1.4M | 0.17% |
| 89 | ACELYRIN INC | 00445A100 | 1,369 | $1.4M | 0.17% |
| 90 | CRISPR THERAPEUTICS AG | CRSP | 30,546 | $1.4M | 0.17% |
| 91 | KALVISTA PHARMACEUTICALS INC | KALV | 142,692 | $1.4M | 0.17% |
| 92 | DISC MEDICINE INC | IRON | 284 | $1.3M | 0.16% |
| 93 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 195,899 | $1.3M | 0.16% |
| 94 | ACUMEN PHARMACEUTICALS INC | ABOS | 315,265 | $1.3M | 0.16% |
| 95 | CYMABAY THERAPEUTICS INC | 23257D103 | 816 | $1.2M | 0.15% |
| 96 | VISTAGEN THERAPEUTICS INC | VTGN | 229,100 | $1.2M | 0.14% |
| 97 | AVROBIO INC | 05455M100 | 718,259 | $1.1M | 0.13% |
| 98 | UNIQURE NV | QURE | 157,365 | $1.1M | 0.13% |
| 99 | KEZAR LIFE SCIENCES INC | KZR | 853,391 | $1.0M | 0.12% |
| 100 | TERNS PHARMACEUTICALS INC | TERN | 2,000 | $1.0M | 0.12% |
| 101 | TERNS PHARMACEUTICALS INC | TERN | 165,480 | $832,365 | 0.10% |
| 102 | JASPER THERAPEUTICS INC | JSPRW | 1,125,087 | $787,561 | 0.09% |
| 103 | ELEVATION ONCOLOGY INC | 28623U101 | 1,171,939 | $776,527 | 0.09% |
| 104 | TYRA BIOSCIENCES INC | TYRA | 48,170 | $663,301 | 0.08% |
| 105 | IMMUNIC INC | IMUX | 450,000 | $661,501 | 0.08% |
| 106 | ELI LILLY & CO | LLY | 1,227 | $659,058 | 0.08% |
| 107 | PROQR THRAPEUTICS N V | N71542109 | 472,625 | $614,412 | 0.07% |
| 108 | AUTOLUS THERAPEUTICS PLC | AUTL | 262,694 | $612,078 | 0.07% |
| 109 | COGENT BIOSCIENCES INC | COGT | 62,766 | $611,969 | 0.07% |
| 110 | IMMATICS N.V | IMTX | 49,031 | $567,778 | 0.07% |
| 111 | KODIAK SCIENCES INC | KOD | 312,881 | $563,186 | 0.07% |
| 112 | KARYOPHARM THERAPEUTICS INC | KPTI | 400,000 | $536,001 | 0.06% |
| 113 | ANEBULO PHARMACEUTICALS INC | ANEB | 157,862 | $503,580 | 0.06% |
| 114 | TRACON PHARMACEUTICALS INC | 89237H209 | 2,765,530 | $492,265 | 0.06% |
| 115 | HOOKIPA PHARMA INC | HOOK | 530,776 | $326,958 | 0.04% |
| 116 | PROTARA THERAPEUTICS INC | TARA | 188,664 | $315,069 | 0.04% |
| 117 | MORPHIC HLDG INC | 61775R105 | 129 | $295,539 | 0.04% |
| 118 | TG THERAPEUTICS INC | TGTX | 32,547 | $272,093 | 0.03% |
| 119 | PTC THERAPEUTICS INC | PTCT | 10,862 | $243,418 | 0.03% |
| 120 | VERONA PHARMA PLC | 925050106 | 318,591 | $213,767 | 0.03% |
| 121 | STOKE THERAPEUTICS INC | STOK | 500 | $197,000 | 0.02% |
| 122 | MEREO BIOPHARMA GROUP PLC | MREO | 591,676 | $191,281 | 0.02% |
| 123 | CHEMOMAB THERAPEUTICS LTD | CMMB | 213,392 | $190,986 | 0.02% |
| 124 | CRISPR THERAPEUTICS AG | CRSP | 39 | $177,021 | 0.02% |
| 125 | SCPHARMACEUTICALS INC | 810648105 | 18,647 | $132,767 | 0.02% |
| 126 | RELMADA THERAPEUTICS INC | RLMD | 40,369 | $121,107 | 0.01% |
| 127 | FOGHORN THERAPEUTICS INC | FHTX | 15,292 | $76,460 | 0.01% |
| 128 | OCULAR THERAPEUTIX INC | OCUL | 21,590 | $67,793 | 0.01% |
| 129 | SYNDAX PHARMACEUTICALS INC | SNDX | 4,000 | $58,080 | 0.01% |
| 130 | SYNLOGIC INC | SYBX | 20,448 | $57,459 | 0.01% |
| 131 | STOKE THERAPEUTICS INC | STOK | 12,116 | $47,736 | 0.01% |
| 132 | XENON PHARMACEUTICALS INC | XENE | 11 | $37,576 | 0.00% |
| 133 | FINCH THERAPEUTICS GROUP INC | FNCHQ | 6,892 | $35,149 | 0.00% |
| 134 | MORPHIC HLDG INC | 61775R105 | 14 | $32,074 | 0.00% |
| 135 | ROIVANT SCIENCES LTD | ROIV | 1,821 | $21,270 | 0.00% |
| 136 | BRAINSTORM CELL THERAPEUTICS | BCLI | 90,242 | $18,057 | 0.00% |
| 137 | ASLAN PHARMACEUTICALS LTD | 04522R200 | 35,420 | $6,215 | 0.00% |
| 138 | INSMED INC | INSM | 2 | $5,050 | 0.00% |
| 139 | FIBROGEN INC | 31572Q808 | 2,774 | $2,393 | 0.00% |
| 140 | PHAXIAM THERAPEUTICS S A | 29604W207 | 301 | $1,558 | 0.00% |